- Home
- AVIR vs IMMR Comparison
AVIR vs IMMR Comparison
Compare AVIR & IMMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVIR | IMMR |
|---|---|---|
| Founded | 2012 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 413.1M | 241.4M |
| IPO Year | 2020 | 1999 |
Fundamental Metrics
Financial Performance| Metric | AVIR | IMMR |
|---|---|---|
| Price | $5.16 | $7.32 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $9.42 | N/A |
| AVG Volume (30 Days) | 271.1K | ★ 344.6K |
| Earning Date | 11-11-2026 | 09-14-2026 |
| Dividend Yield | N/A | ★ 4.04% |
| EPS Growth | ★ 3.00 | N/A |
| EPS | N/A | ★ 0.17 |
| Revenue | ★ $351,367,000.00 | $35,013,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $43.71 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.87 | $5.25 |
| 52 Week High | $6.45 | $8.05 |
Technical Indicators
Market Signals| Indicator | AVIR | IMMR |
|---|---|---|
| Relative Strength Index (RSI) | 47.11 | 49.61 |
| Support Level | $5.01 | $7.09 |
| Resistance Level | $5.76 | $7.65 |
| Average True Range (ATR) | 0.20 | 0.16 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 33.33 | 43.69 |
Price Performance
Historical ComparisonAbout AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
About IMMR Immersion Corporation
Immersion Corp is a licensing company focused on the acceleration, and scaling, through licensing, of haptic technologies that allow people to use sense of touch to engage with products and experience the digital world around them. Its patents cover a wide range of digital technologies and ways in which touch-related technology can be incorporated into and between hardware products and components, systems software, application software, and digital content. It operates in two operating segments: Immersion and Barnes & Noble Education. The majority of revenue is derived from Barnes & Noble Education segment which is a contract operator of physical and virtual bookstores for college and university campuses and K-12 institutions across the United States.